Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 851 $ 28
Prepaid expenses 120 246
Total current assets 971 274
Intangible assets 0 0
Deposits 12 12
Operating lease right-to-use asset 80 110
Fixed assets, net 0 0
Total other assets 92 122
Total assets 1,063 396
Current Liabilities:    
Accounts payable 2,001 1,940
Accrued expenses 1,313 2,379
Accrued interest 3,283 2,029
Operating lease liability 90 120
Line of credit 31 31
Convertible notes 21,844 13,207
Total current liabilities 28,562 19,706
Stockholders' Deficit:    
Common stock - $0.001 par value; 750,000,000 shares authorized; and 75,435,862 and 69,784,699 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively 75 70
Additional paid-in capital 550,389 548,096
Accumulated deficit (577,819) (567,332)
Noncontrolling interest (169) (169)
Total stockholders' deficit (27,499) (19,310)
Total liabilities and stockholders' deficit 1,063 396
Series C    
Stockholders' Deficit:    
Convertible preferred stock 1 1
Series J    
Stockholders' Deficit:    
Convertible preferred stock $ 24 $ 24